McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
807.63
+3.04 (0.38%)
At close: Oct 29, 2025, 4:00 PM EDT
810.00
+2.37 (0.29%)
After-hours: Oct 29, 2025, 7:05 PM EDT
McKesson Market Cap
McKesson has a market cap or net worth of $100.46 billion as of October 29, 2025. Its market cap has increased by 53.22% in one year.
Market Cap
100.46B
Enterprise Value
107.98B
1-Year Change
53.22%
Ranking
Category
Stock Price
$807.63
Market Cap Chart
Since December 1, 1998, McKesson's market cap has increased from $7.05B to $100.46B, an increase of 1,325.26%. That is a compound annual growth rate of 10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 100.08B | 38.34% |
| Dec 31, 2024 | 72.34B | 17.43% |
| Dec 29, 2023 | 61.61B | 15.82% |
| Dec 30, 2022 | 53.19B | 40.15% |
| Dec 31, 2021 | 37.95B | 35.91% |
| Dec 31, 2020 | 27.93B | 12.04% |
| Dec 31, 2019 | 24.92B | 15.48% |
| Dec 31, 2018 | 21.58B | -33.61% |
| Dec 29, 2017 | 32.51B | 2.39% |
| Dec 30, 2016 | 31.75B | -30.03% |
| Dec 31, 2015 | 45.38B | -5.71% |
| Dec 31, 2014 | 48.13B | 29.83% |
| Dec 31, 2013 | 37.08B | 62.00% |
| Dec 31, 2012 | 22.89B | 19.63% |
| Dec 30, 2011 | 19.13B | 7.42% |
| Dec 31, 2010 | 17.81B | 6.34% |
| Dec 31, 2009 | 16.75B | 58.13% |
| Dec 31, 2008 | 10.59B | -44.13% |
| Dec 31, 2007 | 18.96B | 26.34% |
| Dec 29, 2006 | 15.01B | -5.46% |
| Dec 30, 2005 | 15.87B | 71.66% |
| Dec 31, 2004 | 9.25B | -1.34% |
| Dec 31, 2003 | 9.37B | 19.10% |
| Dec 31, 2002 | 7.87B | -26.43% |
| Dec 31, 2001 | 10.70B | 4.95% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.90B |
| Johnson & Johnson | 457.19B |
| AbbVie | 401.86B |
| UnitedHealth Group | 329.86B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 221.56B |